вторник, 14 июня 2016 г.

Valeant Hires Morgan Stanley to Sell Dermatology Assets

Valeant Hires Morgan Stanley to Sell Dermatology Assets


Valeant Pharmaceuticals International Inc. is working with advisers at Morgan Stanley as it weighs the sale of dermatology units Obagi Medical Products and Solta Medical to raise cash to reduce debt, according to people familiar with the matter. The two businesses could fetch up to $500 million and attract interest from other pharmaceutical companies, the people said, asking not to be identified because the deliberations are private.



from Biotech News